Potentiating cancer vaccine efficacy in liver cancer

Hepatocellular carcinoma (HCC) is the most common liver malignancy with a poor prognosis and an overall 5-year survival rate of approximately 5–6%. This is due because standard of care treatment options are limited and none of them shows a sufficient efficacy. HCC is an “inflammation-induced cancer”...

Full description

Bibliographic Details
Main Authors: Maria Tagliamonte, Annacarmen Petrizzo, Angela Mauriello, Maria Lina Tornesello, Franco M Buonaguro, Luigi Buonaguro
Format: Article
Language:English
Published: Taylor & Francis Group 2018-10-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1488564